Moderna (NASDAQ:MRNA) Trading Down 7.9% Following Analyst Downgrade
Moderna, Inc. (NASDAQ:MRNA – Get Free Report) shares were down 7.9% on Thursday after UBS Group lowered their price target on the stock from $96.00 to $78.00. UBS Group currently has a buy rating on the stock. Moderna traded as low as $33.12 and last traded at $33.07. Approximately 7,547,098 shares traded hands during mid-day […]
Moderna, Inc. (NASDAQ:MRNA – Get Free Report) shares were down 7.9% on Thursday after UBS Group lowered their price target on the stock from $96.00 to $78.00. UBS Group currently has a buy rating on the stock. Moderna traded as low as $33.12 and last traded at $33.07. Approximately 7,547,098 shares traded hands during mid-day […]
